1. Introduction
===============

Soft corals have been known to be rich sources of terpenoid metabolites \[[@B1-marinedrugs-12-01148]\]. For the purpose of discovering bioactive agents from marine organisms, we have previously investigated the chemical constituents and reported a series of bioactive natural products from Taiwanese soft corals \[[@B2-marinedrugs-12-01148],[@B3-marinedrugs-12-01148],[@B4-marinedrugs-12-01148],[@B5-marinedrugs-12-01148]\]. In recent studies a series of bioactive eunicellin-based diterpenoids, have been isolated from the soft corals of the genera*Cladiella*, *Klysum* and *Litophyton* sp. \[[@B6-marinedrugs-12-01148],[@B7-marinedrugs-12-01148],[@B8-marinedrugs-12-01148],[@B9-marinedrugs-12-01148],[@B10-marinedrugs-12-01148],[@B11-marinedrugs-12-01148],[@B12-marinedrugs-12-01148],[@B13-marinedrugs-12-01148],[@B14-marinedrugs-12-01148]\]. The soft coral *Cladiella krempfi* has been found to produce several types of metabolites including eunicellin-type diterpenoids \[[@B15-marinedrugs-12-01148],[@B16-marinedrugs-12-01148],[@B17-marinedrugs-12-01148]\] and pregnane-type steroids \[[@B18-marinedrugs-12-01148],[@B19-marinedrugs-12-01148]\]. Our previous chemical investigation of the Formosan soft coral *Cladiella krempfi* also resulted in the isolation of a series of new eunicellin-type diterpenoids, krempfielins A--M \[[@B20-marinedrugs-12-01148],[@B21-marinedrugs-12-01148],[@B22-marinedrugs-12-01148]\]. In this paper, we further report the discovery of three new eunicellin-based diterpenoids, krempfielins N--P (**1**--**3**) ([Chart 1](#marinedrugs-12-01148-f003){ref-type="fig"} and [Supplementary Figures S1--S9](#marinedrugs-12-01148-s001){ref-type="supplementary-material"}). The ability of these compounds to inhibit the superoxide anion generation and elastase release in FMLP/CB-induced human neutrophils was also evaluated. The results showed that compound **3** could inhibit superoxide anion generation while **1** and **3**, especially **1**, effectively inhibited the generation of the elastase release in FMLP/CB-induced human neutrophils.

![Structures of metabolites **1**--**3**.](marinedrugs-12-01148-g003){#marinedrugs-12-01148-f003}

2. Results and Discussion
=========================

The new metabolite krempfielin N (**1**) showed the molecular ion peak \[M + Na\]^+^ at *m*/*z* 461.2882 in the HRESIMS and established a molecular formula of C~25~H~42~O~6~, implying five degrees of unsaturation. The IR absorptions bands at ν~max~ 3445 and 1733 cm^−1^ revealed the presence of hydroxy and ester carbonyl functionalities. The ^13^C NMR spectrum measured in CDCl~3~ showed signals of 25 carbons ([Table 1](#marinedrugs-12-01148-t001){ref-type="table"}) which were assigned by the assistance of the DEPT spectrum to six methyls (including one oxgenate methyl δ~C~ 57.0), six sp^3^ methylenes, one sp^2^ methylene, eight sp^3^ methines (including four oxymethines), four quaternary carbons (including one ester carbonyl). The NMR spectroscopic data of **1** ([Table 1](#marinedrugs-12-01148-t001){ref-type="table"} and [Table 2](#marinedrugs-12-01148-t002){ref-type="table"}) showed the presence of one 1,1-disubstituted double bond (δ~C~ 112.5 CH~2~ and 148.0 C; δ~H~ 5.03 s, and 4.86 s), one methoxy group (δ~H~ 3.34, 3H, s) and one *n*-butyryloxy group (δ~C~ 172.3 C; 37.4 CH~2~; 18.4 CH~2~; and 13.7 CH~3~; δ~H~ 2.30 m, 2H; 1.67 m, 2H; and 0.98 t, 3H, *J* = 7.6 Hz). Therefore, taking account of the two degrees of unsaturation from double bonds, it was suggested that **1** should be a tricyclic compound from the remaining three degrees of unsaturation. The ^1^H--^1^H COSY and HMBC correlations ([Figure 1](#marinedrugs-12-01148-f001){ref-type="fig"}) were further used for establishing the molecular skeleton of **1**. The COSY experiment assigned three isolated consecutive proton spin systems. Above evidences and the analysis of HMBC spectrum ([Figure 1](#marinedrugs-12-01148-f001){ref-type="fig"}) suggested that **1** is an eunicellin-based diterpenoid. Furthermore, the two hydroxy groups attaching at C-7 and C-12 were confirmed by the HMBC correlations from one methyl (δ~H~ 1.12 s, H-16) and one oxymethine (δ~H~ 4.12 m, H-6) to the oxygenated quaternary carbon appearing at δ 75.8 (C-7), and one methine (δ~H~ 2.91 t, H-10) and one proton of H~2~-17 (δ~H~ 5.03 s) to the oxymethine carbon appearing at δ 71.0 (C-12). Thus, the remaining one *n*-butyryloxy group had to be positioned at C-3, an oxygen-bearing quaternary carbon resonating at δ 86.5 ppm. On the basis of above analysis, the planar structure of **1** was established. The stereochemistry of **1** was finally confirmed by the very similar NOE correlations of both **1** and krempfielin L \[[@B22-marinedrugs-12-01148]\].
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###### 

^13^C NMR data for compounds **1**--**3**.

                    1 ^a^          2 ^b^          3 ^a^
  ----------------- -------------- -------------- --------------
  1                 44.4, CH ^c^   45.1, CH       43.2, CH ^c^
  2                 91.0, CH       91.5, CH       90.7, CH
  3                 86.5, C        85.7, C        84.5, C
  4                 36.0, CH~2~    35.7, CH~2~    28.7, CH~2~
  5                 26.7, CH~2~    28.9, CH~2~    35.4, CH~2~
  6                 89.7, CH       77.5, CH       67.0, CH
  7                 75.8, C        79.4, C        152.5, C
  8                 45.2, CH~2~    79.0, CH       77.2, CH
  9                 80.0, CH       79.4, CH       85.0, CH
  10                51.4, CH       50.1, CH       46.6, CH
  11                148.0, C       143.6, C       141.4, C
  12                71.0, CH       73.5, CH       73.2, CH
  13                30.7, CH~2~    29.2, CH~2~    29.0, CH~2~
  14                36.6, CH       37.2, CH       36.9, CH
  15                23.2, CH~3~    23.1, CH~3~    22.1, CH~3~
  16                23.6, CH~3~    18.0, CH~3~    118.1, CH~2~
  17                112.5, CH~2~   115.1, CH~2~   119.4, CH~2~
  18                28.8, CH       28.6, CH       26.9, CH
  19                16.0, CH~3~    15.6, CH~3~    15.3, CH~3~
  20                21.8, CH~3~    21.7, CH~3~    21.6, CH~3~
  3- *n*-butyrate   172.3, C       173.0, C       172.5, C
  37.4, CH~2~       36.7, CH~2~    37.4, CH~2~    
  18.4, CH~2~       18.5, CH~2~    18.5, CH~2~    
  13.7, CH~3~       13.5, CH~3~    13.6, CH~3~    
  6-OMe             57.0, CH~3~                   
  8-OAc                            170.7, C       
  21.4, CH~3~                                     
  12-OAc                           170.2, C       170.1, C
  21.6, CH~3~       21.7, CH~3~                   

^a13^C spectra recorded at 100 MHz in CDCl~3~;^b13^C spectra recorded at 125 MHz in CDCl~3~; ^c^Deduced from DEPT.
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###### 

^1^H NMR data for compounds **1**--**3**.

                    1 ^a^              2 ^b^                 3 ^a^
  ----------------- ------------------ --------------------- -------------------------
  1                 2.25 m             2.28 dd (10.0, 7.0)   2.26 m
  2                 3.70 br s          3.67 br s             3.84 br s
  3                                                          
  4                 1.86 m, 2.64 m     1.85 m, 2.66 m        1.68 m, 2.66 m
  5                 1.33 m, 1.65 m     1.49 m, 1.65 m        1.76 m
  2.21 m                                                     
  6                 4.12 m             4.66 d (6.5)          4.75 dd (10.8, 4.4) ^d^
  7                                                          
  8                 1.82 m             5.19 d (10.0)         4.20 s
  9                 4.53 m             4.31 dd (10.0, 6.5)   4.43 d (10.8)
  10                2.91 t (6.4) ^c^   3.38 dd (7.0, 7.0)    2.90 dd (10.8, 8.4)
  11                                                         
  12                4.39 s             5.43 dd (4.0, 3.0)    5.49 t (2.8)
  13                1.36 m, 1.86 m     1.37 m, 1.93 m        1.30 m, 1.98 m
  14                1.86 m             1.70 m                1.71 m
  15                1.45 s             1.45 s                1.65 s
  16                1.12 s             1.08 s                5.23 s, 5.55 s
  17                4.86 s, 5.03 s     4.84 s, 5.10 s        4.96 d (1.6)
  5.27 d (1.6)                                               
  18                1.81 m             1.80 m                1.96 m
  19                0.82 d (7.6)       0.80 d (7.0)          0.75 d (6.8)
  20                0.99 d (7.2)       0.95 d (7.0)          0.95 d (6.8)
  3- *n*-butyrate   2.30 m             2.60 m, 2.50 m        2.12 m
  1.67 m            1.67 m             1.58 m                
  0.98 t (7.6)      1.00 t (7.5)       0.92 t (7.6)          
  6-OMe             3.34 s                                   
  8-OAc                                2.07 s                
  12-OAc                               2.08 s                2.05 s

^a1^H spectra recorded at 400 MHz in CDCl~3~;^b1^Hspectra recorded at 500 MHz in CDCl~3~;^c^*J* values (Hz) in parentheses.

![Selected ^1^H−^1^H COSY (▬) and HMBC (→) correlations of **1**, **2** and **3**.](marinedrugs-12-01148-g001){#marinedrugs-12-01148-f001}

Krempfielin O (**2**) was shown by HRESIMS to possess the molecular formula C~28~H~44~O~9~ (*m*/*z* 547.2880 \[M + Na\]^+^). The NMR spectroscopic data of **2** ([Table 1](#marinedrugs-12-01148-t001){ref-type="table"} and [Table 2](#marinedrugs-12-01148-t002){ref-type="table"}) showed the presence of two acetoxy groups (δ~H~ 2.07, s and 2.08, s, each 3H; and δ~C~ 170.7, C and 170.2, C; 21.4, CH~3~ and 21.6, CH~3~), and an *n*-butyryloxy group (δ~H~ 2.60 m and 2.50 m, each 1H; 1.67 m, 2H and 1.00 t, 3H, *J* = 7.5 Hz; and δ~C~ 173.0, C; 36.7, CH~2~; 18.5, CH~2~ and 13.5, CH~3~). As demonstrated by the HMBC correlation from oxymethine proton H-8 (δ 5.19) to the ester carbonyl carbon appearing at δ~C~ 170.7 ([Figure 1](#marinedrugs-12-01148-f001){ref-type="fig"}), one acetoxy group was positioned at C-8. The position of an *n*-butyryloxy group at C-3 was established by NOE interaction between the methylene protons (δ 1.67) of *n*-butyryloxy group with H-5 (δ 1.49). The remaining one acetoxy group was thus positioned at C-12. The relative configuration of **2** was further confirmed by NOE correlations ([Figure 2](#marinedrugs-12-01148-f002){ref-type="fig"}).

![Key NOESY correlations for **2** and **3**.](marinedrugs-12-01148-g002){#marinedrugs-12-01148-f002}

The related metabolite, krempfielin P (**3**), had a molecular formula of C~26~H~40~O~7~ as indicated by the HRESIMS (*m*/*z* 487.2675, \[M + Na\]^+^) and NMR data ([Table 1](#marinedrugs-12-01148-t001){ref-type="table"} and [Table 2](#marinedrugs-12-01148-t002){ref-type="table"}). The ^13^C NMR spectrum of **3** revealed the appearance of two ester carbonyls (δ~C~ 172.5 and 170.1), which were correlated with one methylene (δ~H~ 2.12 m, 2H; and δ~C~ 37.4) of an *n*-butyrate and the methyl (δ~H~ 2.05 s, 3H; δ~C~ 21.7CH~3~) of an acetate group, respectively. The planar structure of **3** was determined by ^1^H--^1^H COSY and HMBC correlations ([Figure 1](#marinedrugs-12-01148-f001){ref-type="fig"}). Comparison of the NMR data of **3** with those of the compound krempfielin A \[[@B20-marinedrugs-12-01148]\] revealed that the only difference is the replacement of one methyl and one hydroxy group at C-7 in krempfielin A by the substitution of one olefinic methylene (δ~C~ 118.1, CH~2~; δ~H~ 5.55, s and 5.23, s) in **3**. The placement of one *n*-butyryloxy group and one acetoxy group at C-3 and C-12, respectively was established by comparison of the spectroscopic data with those of krempfielin A. The relative configuration of **3** was mostly determined to be the same as that of krempfielin A by comparison of the chemical shifts of both compounds and was further confirmed by NOE correlations ([Figure 2](#marinedrugs-12-01148-f002){ref-type="fig"}).

Recently, we discovered several eunicellins showed anti-inflammatory activity by significantly inhibiting superoxide anion generation and elastase release in human neutrophiles induced by *N*-formyl-methionyl-leucyl-phenylalanine/cytochalasin B (FMLP/CB) \[[@B22-marinedrugs-12-01148],[@B23-marinedrugs-12-01148]\]. The same*in vitro* anti-inflammatory effects of the diterpenoids **1**--**3** also were tested in this study ([Table 3](#marinedrugs-12-01148-t003){ref-type="table"}). At a concentration of 10 µM, **1** and **2** could not significantly reduce the generation of superoxide anion, however, **3** inhibited 23.32% ± 5.88% generation of superoxide anion, relative to the control cells stimulated with FMLP/CB only. At the same concentration, all of **1**--**3** were found to show anti-inflammatory activity by inhibiting the elastase release. Compound **1** displayed significant inhibition (73.86% ± 14.18%) at this concentration with IC~50~ of 4.94 ± 1.68 µM in this assay.
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###### 

Effect of pure compounds on elastase release in *N*-formyl-methionyl-leucyl-phenylalanine/cytochalasin B (FMLP/CB)-induced human neutrophils.

  Compound   Elastase                 
  ---------- --------------- -------- -------------
  **1**      73.86 ± 14.18   \*\*     4.94 ± 1.68
  **2**      13.33 ± 3.56    \*       \>10
  **3**      35.54 ± 3.17    \*\*\*   \>10

Percentage of inhibition (%) was measured at 10 µM; results are presented as mean ± S.E.M. (*n* = 3 or 4); **\****p* \< 0.05, **\*\*** *p* \< 0.01 and **\*\*\****p* \< 0.001 compared with the control value.

3. Experimental Section
=======================

3.1. General Experimental Procedures
------------------------------------

Melting point was determined using a Fisher-Johns melting point apparatus. Optical rotations were measured on a JASCO P-1020 polarimeter. IR spectra were recorded on a JASCO FT/IR-4100 infrared spectrophotometer. ESIMS were obtained with a Bruker APEX II mass spectrometer. The NMR spectra were recorded either on a Varian UNITY INOVA-500 FT-NMR and a Varian 400MR FT-NMR. Silica gel (Merck, Darmstadt, Germany, 230--400 mesh) was used for column chromatography. Precoated silica gel plates (Merck, Darmstadt, Germany, Kieselgel 60 F-254, 0.2 mm) were used for analytical thin layer chromatography (TLC). High performance liquid chromatography was performed on a Hitachi L-7100 HPLC apparatus with an octadecylsilane (ODS) column (250 × 21.2 mm, 5 µm).

3.2. Animal Material
--------------------

*C. krempfi* was collected by hand using scuba off the coast of Penghu islands of Taiwan in June 2008, at a depth of 5--10 m, and stored in a freezer until extraction. A voucher sample (specimen No. 200806CK) was deposited at the Department of Marine Biotechnology and Resources, National Sun Yat-sen University*.*

3.3. Extraction and Separation
------------------------------

The octocoral (1.1 kg fresh wt) was collected and freeze-dried. The freeze-dried material was minced and extracted exhaustively with EtOH (3 × 10 L). The EtOH extract of the frozen organism was partitioned between CH~2~Cl~2~ and H~2~O. The CH~2~Cl~2~-soluble portion (14.4 g) was subjected to column chromatography on silica gel and eluted with EtOAc in *n*-hexane (0%--100% of EtOAc, stepwise) and then further with MeOH in EtOAc with increasing polarity to yield 41 fractions. Fraction 31, eluted with *n*-hexane--EtOAc (1:10), was rechromatoraphed over a silica gel open column using *n*-hexane--acetone (3:1) as the mobile phase to afford eight subfractions (A1--A8). Subfraction A4 was repeatedly separated by reverse phase HPLC (CH~3~CN--H~2~O, 0.8:1 to 1:1) to afford compound **1** (3.2 mg). Subfraction A5 separated by reverse phase HPLC (CH~3~CN--H~2~O, 1:1 to 1:1.6) to afford compound **2** (1.2 mg). Subfraction A6 by reverse phase HPLC (CH~3~CN--H~2~O, 1:1.5) to afford compound **3** (3.9 mg).

### 3.3.1. Krempfielin N (1)

Colorless oil; ![](marinedrugs-12-01148-i001.jpg) = +27.3 (*c* 0.91, CHCl~3~); IR (neat) ν~max~ 3445, 2961, 1733, 1457, 1370, 1180, and 1084 cm^−1^; ^13^C and ^1^H NMR data, see [Table 1](#marinedrugs-12-01148-t001){ref-type="table"} and [Table 2](#marinedrugs-12-01148-t002){ref-type="table"}; ESIMS *m*/*z* 461 \[M + Na\]^+^; HRESIMS *m*/*z* 461.2882 \[M + Na\]^+^ (calcd. for C~25~H~42~O~6~Na, 461.2879).

### 3.3.2. Krempfielin O (2)

Colorless oil; ![](marinedrugs-12-01148-i001.jpg) = −56.7 (*c* 0.3, CHCl~3~); IR (neat) ν~max~ 3461, 2960, 1735, 1464, 1372, 1238, 1177, 1076, and 1026 cm^−1^; ^13^C and ^1^H NMR data, see [Table 1](#marinedrugs-12-01148-t001){ref-type="table"} and [Table 2](#marinedrugs-12-01148-t002){ref-type="table"}; ESIMS *m*/*z* 547 \[M + Na\]^+^; HRESIMS *m*/*z* 547.2880 \[M + Na\]^+^ (calcd. for C~28~H~44~O~9~Na, 547.2883).

### 3.3.3. Krempfielin P (3)

Colorless oil; ![](marinedrugs-12-01148-i001.jpg) = +13.1 (*c* 3.8, CHCl~3~); IR (neat) ν~max~ 3419, 2959, 1733, 1437, 1371, 1237, 1182, and 1072 cm^−1^; ^13^C and ^1^H NMR data, see [Table 1](#marinedrugs-12-01148-t001){ref-type="table"} and [Table 2](#marinedrugs-12-01148-t002){ref-type="table"}; ESIMS *m*/*z* 487 \[M + Na\]^+^; HRESIMS *m*/*z* 487.2675 \[M + Na\]^+^ (calcd for C~26~H~40~O~7~Na, 487.2672).

3.4. *In Vitro* Anti-Inflammatory Assay---Superoxide Anion Generation and Elastase Release by Human Neutrophils
---------------------------------------------------------------------------------------------------------------

Human neutrophils were obtained by means of dextran sedimentation and Ficoll centrifugation. Measurements of superoxide anion generation and elastase release were carried out according to previously described procedures \[[@B24-marinedrugs-12-01148],[@B25-marinedrugs-12-01148]\]. LY294002, a phosphatidylinositol-3-kinase inhibitor, was used as a positive control for inhibition of superoxide anion generation and elastase release with IC~50~ values of 1.88 ± 0.45 and 4.12 ± 0.92 µM, respectively. Briefly, superoxide anion production was assayed by monitoring the superoxide dismutase-inhibitable reduction of ferricytochrome c. Elastase release experiments were performed using MeO-Suc-Ala-Ala-Pro-Val-*p*-nitroanilide as the elastase substrate.

4. Conclusions
==============

New eunicellin-based diterpenoids were isolated from the soft coral *Cladiella krempfi.* Compounds **1** and **3**, especially **1**, could significantly inhibit the release of elastase in FMLP/CB-induced human neutrophils, and **3** inhibited 23% generation of superoxide anion. Thus, compounds **1** and **3** are promising anti-inflammatory agents and may warrant further biomedical investigation.
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